📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Algenex

1.1 - Company Overview

Algenex Logo

Algenex

Headquarter: Spain
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of vector-based technologies to manufacture recombinant proteins via a baculovirus expression vector system, with applications in vaccines, diagnostic reagents, crystallography, HTS and therapeutic molecules. Offers CrisBio, animal vaccine development/production, and biocomponents for diagnostic and therapeutic markets in human and animal health.

Products and services

  • Biocomponents: Diagnostic-grade production of antigens, proteins, growth factors, enzymes, and cytokines for human and animal markets, supplying materials for diagnostic reagents and therapeutic applications
  • CrisBio: Vector-based platform that produces recombinant proteins using a baculovirus expression vector system, architecting vaccines and other biologics for animal and human health, including diagnostic reagents and therapeutic molecules
  • Animal Vaccines: Baculovirus-enabled development and production of vaccines for animal health, leveraging 20 years of experience and pharmaceutical collaborations to build effective immunization products

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Algenex

Polyplus Transfection Logo

Polyplus Transfection

HQ: France Website
  • Description: Provider of innovative solutions for in vivo, in vitro and ex vivo delivery of nucleic acids for research, bioproduction and therapeutics, including transfection reagents for lentiviral (FectoVIR®-LV) and AAV production (FectoVIR®-AAV), PEIpro® for viral vector bioproduction, in vivo–jetPEI®, LipidBrick® Library for LNP formulation, and in vivo-jetRNA®+ for mRNA/saRNA delivery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Polyplus Transfection company profile →
Prolific Machines Logo

Prolific Machines

HQ: United States Website
  • Description: Provider of light-controlled gene expression and closed-loop control technologies to unlock production of next-generation therapeutics, offering a Biological Assembly Line that significantly lowers cell production costs, partnership opportunities for companies using its biomanufacturing technologies, and career opportunities to advance sustainable biomanufacturing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Prolific Machines company profile →
MILabs Logo

MILabs

HQ: The Netherlands Website
  • Description: Provider of high-end molecular imaging solutions for biomedical research, including systems for quantitative 3D functional imaging of SPECT (U-SPECT) and PET (U-PET) tracers, an integrated PET/SPECT platform for simultaneous high-resolution imaging (VECTor), and automated quantitative 3D autoradiography of tissue samples with multiple isotopes (EXIRAD-3D).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MILabs company profile →
Tentarix Logo

Tentarix

HQ: United States Website
  • Description: Provider of protein therapeutics and discovery platforms leveraging synthetic biology, including the Tentacles platform for multifunctional, conditionally active antibody-based biologics that activate immune cells and modulate disease while minimizing safety concerns; CellSurf to understand cell surface proteomes; HuTARG mammalian display to discover fully human binders; and FunctionSeq high-throughput screening of multifunctional biologics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tentarix company profile →
M2P Labs Logo

M2P Labs

HQ: Germany Website
  • Description: Provider of microbioreactor and biochemical engineering solutions, including the BioLector high-throughput microbioreactor for microliter-scale fermentation with online monitoring (biomass, pH, dissolved oxygen, fluorescence); the RoboLector automated cultivation platform with liquid handling; and the FlowerPlate microtiter plate for enhanced oxygen transfer, plus technical/application support, demos, installation, and maintenance contracts.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full M2P Labs company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Algenex

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Algenex

2.2 - Growth funds investing in similar companies to Algenex

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Algenex

4.2 - Public trading comparable groups for Algenex

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Algenex

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Algenex

What does Algenex do?

Algenex is a provider of vector-based technologies to manufacture recombinant proteins via a baculovirus expression vector system, with applications in vaccines, diagnostic reagents, crystallography, HTS and therapeutic molecules. Offers CrisBio, animal vaccine development/production, and biocomponents for diagnostic and therapeutic markets in human and animal health.

Who are Algenex's competitors?

Algenex's competitors and similar companies include Polyplus Transfection, Prolific Machines, MILabs, Tentarix, and M2P Labs.

Where is Algenex headquartered?

Algenex is headquartered in Spain.

How many employees does Algenex have?

Algenex has 1,000 employees 🔒.

When was Algenex founded?

Algenex was founded in 2010 🔒.

What sector and industry vertical is Algenex in?

Algenex is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Algenex

Who are the top strategic acquirers in Algenex's sector and industry

Top strategic M&A buyers and acquirers in Algenex's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Algenex?

Top strategic M&A buyers groups and sectors for Algenex include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Algenex's sector and industry vertical

Which are the top PE firms investing in Algenex's sector and industry vertical?

Top PE firms investing in Algenex's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Algenex's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Algenex's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Algenex's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Algenex include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Algenex's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Algenex?

The key public trading comparables and valuation benchmarks for Algenex include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Algenex for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Algenex with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Algenex's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Algenex with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Algenex's' sector and industry vertical?

Access recent funding rounds and capital raises in Algenex's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Algenex